Page last updated: 2024-11-05

pirinixic acid and Tobacco Use Disorder

pirinixic acid has been researched along with Tobacco Use Disorder in 1 studies

pirinixic acid: structure

Tobacco Use Disorder: Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.

Research Excerpts

ExcerptRelevanceReference
"To evaluate PPARα activation in nicotine dependence we used the selective and potent PPARα agonist, WY-14643 and the clinically used PPARα activator, fenofibrate, in nicotine CPP and we observed attenuation of nicotine preference, but fenofibrate was less potent."1.46In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence. ( Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jackson, A1
Bagdas, D1
Muldoon, PP1
Lichtman, AH1
Carroll, FI1
Greenwald, M1
Miles, MF1
Damaj, MI1

Other Studies

1 other study available for pirinixic acid and Tobacco Use Disorder

ArticleYear
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Neuropharmacology, 2017, 05-15, Volume: 118

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Co

2017